Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akseli Hemminki

Showing results (71-80 of 280) with videos related to

Pageof 28
Sort By:
European Journal of Endocrinology|March 4, 2024
Major improvement in thyroid cancer survival of elderly patients in the Nordic countriesFrantišek Zitrický, Anni Koskinen, Vaclav Liska, et al.
Cancer Medicine|August 3, 2024
Survival improvements in esophageal and gastric cancers in the Nordic countries favor younger patientsKari Hemminki, Frantisek Zitricky, Asta Försti, et al.
Cancer Medicine|September 22, 2020
Rate differences between first and second primary cancers may outline immune dysfunction as a key risk factorGuoqiao Zheng, Kristina Sundquist, Jan Sundquist, et al.
Breast Cancer Research and Treatment|August 25, 2017
Familial associations of male breast cancer with other cancersGuoqiao Zheng, Hongyao Yu, Akseli Hemminki, et al.
International Journal of Cancer|March 29, 2025
Sex specific familial risk in lung cancer through changing histologies in SwedenKari Hemminki, Frantisek Zitricky, Kristina Sundquist, et al.
Lung Cancer (Amsterdam, Netherlands)|March 21, 2025
Lung cancer risk between maternal and paternal half-siblings points to main environmental causation and targets for preventionKari Hemminki, Frantisek Zitricky, Kristina Sundquist, et al.
Plos One|April 16, 2013
Mutation of the fiber shaft heparan sulphate binding site of a 5/3 chimeric adenovirus reduces liver tropismAnniina Koski, Eerika Karli, Anja Kipar, et al.
Cancer Medicine|November 29, 2025
Second Primary Lung Cancer Associated With Family History of Lung CancerFrantisek Zitricky, Kristina Sundquist, Jan Sundquist, et al.
European Urology Open Science|August 2, 2021
Treatment of Advanced Renal Cell Carcinoma: Immunotherapies Have Demonstrated Overall Survival Benefits While Targeted Therapies Have NotOtto Hemminki, Nathan Perlis, Johan Bjorklund, et al.
Blood|December 8, 2009
A recombinant adenovirus type 35 fiber knob protein sensitizes lymphoma cells to rituximab therapyHongjie Wang, Ying Liu, Zong-Yi Li, et al.
Pageof 28

Showing results (71-80 of 280) with videos related to

Sort By:
Pageof 28
European Journal of Endocrinology|March 4, 2024
Major improvement in thyroid cancer survival of elderly patients in the Nordic countriesFrantišek Zitrický, Anni Koskinen, Vaclav Liska, et al.
Cancer Medicine|August 3, 2024
Survival improvements in esophageal and gastric cancers in the Nordic countries favor younger patientsKari Hemminki, Frantisek Zitricky, Asta Försti, et al.
Cancer Medicine|September 22, 2020
Rate differences between first and second primary cancers may outline immune dysfunction as a key risk factorGuoqiao Zheng, Kristina Sundquist, Jan Sundquist, et al.
Breast Cancer Research and Treatment|August 25, 2017
Familial associations of male breast cancer with other cancersGuoqiao Zheng, Hongyao Yu, Akseli Hemminki, et al.
International Journal of Cancer|March 29, 2025
Sex specific familial risk in lung cancer through changing histologies in SwedenKari Hemminki, Frantisek Zitricky, Kristina Sundquist, et al.
Lung Cancer (Amsterdam, Netherlands)|March 21, 2025
Lung cancer risk between maternal and paternal half-siblings points to main environmental causation and targets for preventionKari Hemminki, Frantisek Zitricky, Kristina Sundquist, et al.
Plos One|April 16, 2013
Mutation of the fiber shaft heparan sulphate binding site of a 5/3 chimeric adenovirus reduces liver tropismAnniina Koski, Eerika Karli, Anja Kipar, et al.
Cancer Medicine|November 29, 2025
Second Primary Lung Cancer Associated With Family History of Lung CancerFrantisek Zitricky, Kristina Sundquist, Jan Sundquist, et al.
European Urology Open Science|August 2, 2021
Treatment of Advanced Renal Cell Carcinoma: Immunotherapies Have Demonstrated Overall Survival Benefits While Targeted Therapies Have NotOtto Hemminki, Nathan Perlis, Johan Bjorklund, et al.
Blood|December 8, 2009
A recombinant adenovirus type 35 fiber knob protein sensitizes lymphoma cells to rituximab therapyHongjie Wang, Ying Liu, Zong-Yi Li, et al.
Pageof 28